Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Return on Equity [ROE] (2020 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) posted Return on Equity [ROE] of 18.99% for Q2 2026, down 5.24 percentage points from 24.22% a year earlier but up 2.63 percentage points from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Harmony Biosciences Holdings' Return on Equity [ROE] came in at 20.75%, down 5.09 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for three consecutive years, with a four-year change of -3.64 percentage points (FY2021 to FY2025).
  • In prior years, Harmony Biosciences Holdings' Return on Equity [ROE] was 25.84% in FY2024 (-3.79 pp), 29.63% in FY2023 (-31.96 pp), 61.58% in FY2022 (+37.19 pp) and 24.39% in FY2021.
  • Quarterly Return on Equity [ROE] has run from a low of 8.38% in Q3 2021 to a high of 52.73% in Q3 2022 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of -3.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 58.98 percentage points; the weakest was Q3 2023, with a drop of 21.54 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 16.36% (Q1 2026), 18.61% (Q4 2025) and 23.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn 18.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.99%
Mar 31, 2026 16.36%
Dec 31, 2025 18.61%
Sep 30, 2025 23.09%
Jun 30, 2025 24.22%
Mar 31, 2025 22.14%
Dec 31, 2024 23.17%
Sep 30, 2024 21.60%
Jun 30, 2024 21.82%
Mar 31, 2024 28.03%
Dec 31, 2023 27.17%
Sep 30, 2023 31.20%
Jun 30, 2023 43.14%
Mar 31, 2023 44.80%
Dec 31, 2022 48.60%
Sep 30, 2022 52.73%
Jun 30, 2022 25.21%
Mar 31, 2022 24.29%
Dec 31, 2021 20.44%
Sep 30, 2021 8.38%
API Access

Harmony Biosciences Holdings Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEY